CNSY · NASDAQ
Cerenome (CNSY) Stock Price & Fundamentals
Cerenome (CNSY) closed at $444.15 on Oct 9, 2026, up 0.02% from the previous close of $444.08.
Share price, past year
1Y −13.59%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $444.15 |
| Sep 30, 2026 | $428.39 |
| Aug 31, 2026 | $441.76 |
| Jul 31, 2026 | $429.74 |
| Jun 30, 2026 | $435.59 |
| May 29, 2026 | $459.20 |
| Apr 30, 2026 | $447.89 |
| Mar 31, 2026 | $470.14 |
| Feb 27, 2026 | $444.28 |
| Jan 30, 2026 | $458.53 |
| Dec 31, 2025 | $456.37 |
| Nov 28, 2025 | $450.83 |
| Oct 31, 2025 | $485.42 |
Key statistics
- Market cap
- $3.25B
- P/E (TTM)
- 21.8
- EPS (TTM)
- $20.41
- Revenue (TTM)
- $4.20M
- Net income (TTM)
- −$26.09M
- Shares outstanding
- 7.3M
- Dividend yield
- —
- 52-week range
- $427.47 – $514.02
Cerenome's market cap is $3.25B, based on a share price of $444.15 and 7.3M shares outstanding as of Jun 30, 2026.
Financials
Cerenome reported revenue of $5.21M for fiscal 2025, down 10.49% from fiscal 2024.
Cerenome reported a net loss of $22.39M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $5.21M | −10.5% | −$22.39M | −429.4% | −$7.25 | −$20.84M |
| FY2024ended Dec 31, 2024 | $5.82M | +18.5% | −$12.98M | −222.8% | −$58.50 | −$10.70M |
| FY2023ended Dec 31, 2023 | $4.91M | +33.8% | −$13.32M | −271.0% | −$106.00 | −$13.01M |
| FY2018ended Dec 31, 2018 | $3.67M | +36.5% | −$12.63M | −344.2% | −$2,174.50 | −$12.11M |
| FY2017ended Dec 31, 2017 | $2.69M | −42.3% | −$22.69M | −843.7% | −$205.75 | −$18.42M |
| FY2016ended Dec 31, 2016 | $4.66M | −3.8% | −$22.05M | −473.5% | −$32.00 | — |
| FY2015ended Dec 31, 2015 | $4.84M | −2.3% | — | — | — | — |
| FY2014ended Dec 31, 2014 | $4.95M | −30.5% | — | — | — | — |
| FY2013ended Dec 31, 2013 | $7.12M | −18.2% | — | — | — | −$35.08M |
| FY2012ended Dec 31, 2012 | $8.71M | — | — | — | — | −$33.40M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $411.00K | −$9.01M | −$1.31 |
| Q1 FY2026ended Mar 31, 2026 | $1.03M | −$6.95M | −$1.05 |
| Q4 FY2025ended Dec 31, 2025 | $1.37M | −$5.71M | $23.77 |
| Q3 FY2025ended Sep 30, 2025 | $1.40M | −$4.42M | −$1.00 |
| Q2 FY2025ended Jun 30, 2025 | $1.39M | $5.15M | −$0.16 |
| Q1 FY2025ended Mar 31, 2025 | $1.06M | −$17.40M | −$29.86 |
| Q4 FY2024ended Dec 31, 2024 | $1.41M | −$3.90M | −$12.75 |
| Q3 FY2024ended Sep 30, 2024 | $1.46M | −$2.87M | −$9.25 |
Company profile
- Name
- Cerenome, Inc.
- Ticker
- CNSY
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 6420 Levit Green Boulevard, Suite 310, Houston, TX 77021
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001095981
Recent SEC filings
- Oct 2, 2026
- Sep 10, 2026
- Aug 14, 2026
- Aug 14, 2026
- Aug 4, 2026
- Jun 5, 2026
- May 15, 2026
- May 15, 2026
Frequently asked questions
What is Cerenome's stock price?
Cerenome (CNSY) closed at $444.15 on Oct 9, 2026, up 0.02% from the previous close of $444.08.
What is Cerenome's market cap?
Cerenome's market cap is $3.25B, based on a share price of $444.15 and 7.3M shares outstanding as of Jun 30, 2026.
How much revenue does Cerenome make?
Cerenome reported revenue of $5.21M for fiscal 2025, down 10.49% from fiscal 2024.
What is CNSY's P/E ratio?
Cerenome's price-to-earnings ratio is 21.8, based on trailing twelve-month diluted EPS of $20.41.
Does Cerenome pay a dividend?
Cerenome's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cerenome, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures